Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study

Overview of attention for article published in American Journal of Hematology, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 1 X post from an account with 711 followers.

Age and dPCR can predict relapse in CML patients who discontinued imatinib: the ISAV study. - PubMed - NCBI https://t.co/evQ2uIKRDD

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.